Key Documents

View All Documentation

159883

2-Methoxybenzylamine

Name: 2-Methoxybenzylamine
Brand: ALDRICH

98%

Select a Size

Change View

About This Item

Linear Formula:

CH₃OC₆H₄CH₂NH₂

CAS Number:

6850-57-3

Molecular Weight:

137.18

UNSPSC Code:

12352100

NACRES:

NA.22

PubChem Substance ID:

24849838

EC Number:

229-941-7

Beilstein/REAXYS Number:

1100448

MDL number:

MFCD00008110

Assay:

98%

Form:

liquid

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

Quality Level

100

assay

98%

form

liquid

refractive index

n20/D 1.548 (lit.)

bp

227 °C/724 mmHg (lit.)

density

1.051 g/mL at 25 °C (lit.)

functional group

amine

SMILES string

COc1ccccc1CN

InChI

1S/C8H11NO/c1-10-8-5-3-2-4-7(8)6-9/h2-5H,6,9H2,1H3

InChI key

PXJACNDVRNAFHD-UHFFFAOYSA-N

Description

Application

2-Methoxybenzylamine was used in the preparation of 6-substituted purines.

pictograms

GHS05

signalword

Danger

hcodes

H314

pcodes

P280 - P303 + P361 + P353 - P304 + P340 + P310 - P305 + P351 + P338 - P363 - P405

Hazard Classifications

Skin Corr. 1B

Storage Class

8A - Combustible corrosive hazardous materials

wgk

WGK 3

flash_point_f

212.0 °F - closed cup

flash_point_c

100 °C - closed cup

ppe

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Synthesis and in vitro biological evaluation of 2,6,9-trisubstituted purines targeting multiple cyclin-dependent kinases.

Marek Zatloukal et al.

European journal of medicinal chemistry, 61, 61-72 (2012-07-10)

Several inhibitors of cyclin-dependent kinases (CDKs), including the 2,6,9-trisubstituted purine derivative roscovitine, are currently being evaluated in clinical trials as potential anticancer drugs. Here, we describe a new series of roscovitine derivatives that show increased potency in vitro. The series

Global Trade Item Number

SKU	GTIN
159883-25G	04061838744821
159883-5G	04061838744838